Amarin Corp. Plc (AMRN)
14.71
+0.51
(+3.59%)
USD |
NASDAQ |
Jun 09, 14:15
Amarin SG&A Expense (Quarterly) : 19.35M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Akari Therapeutics Plc | 2.165M |
| Cellectis SA | 5.610M |
| Agenus, Inc. | 6.86M |
| Grifols SA | 328.75M |
| Trinity Biotech Plc | 7.304M |